Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Increasing mir-302 turns human hair cells into stem cells by changing gene regulation and demethylation.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Hair loss linked to higher heart disease risk in both men and women.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

A very low-calorie ketogenic diet is effective for quick weight loss and improving health in obese patients, with careful management of side effects and maintenance.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.